Key result
High body mass index-attributable ischemic heart disease resulted in 1,662,339 deaths globally in 2019, with the age-standardized death rate showing a declining trend (EAPC -0.67) from 1990 to 2019.
Why the study?
The study evaluated the global burden of ischemic heart disease attributable to high body mass index using data from the Global Burden of Disease 2019.
Observational
Effect estimate: EAPC -0.67 (95% CI -0.75 to -0.60)
While age-standardized rates of ischemic heart disease attributable to high BMI have slightly decreased globally over 30 years, the absolute number of deaths and DALYs has significantly increased, particularly in low-middle SDI regions.
BACKGROUND: The objective of this study is to evaluate the global burden of ischemic heart disease (IHD) attributable to High body mass index (HBMI) by utilizing data from Global Burden of Disease (GBD) 2019. METHODS: This study utilized data from the GBD 2019 to examine the impact of HBMI on deaths and disability-adjusted life years (DALYs). The analysis focused on age-standardized rates and considered a 30-year time frame. Trends were assessed using estimated annual percentage changes (EAPCs). RESULTS: Since 1990, a significant global increase in IHD attributable to HBMI has been observed. This increase is particularly notable among elderly males and in regions with low-middle Socio-Demographic Index (SDI), such as Central Asia and Eastern Europe. In 2019, IHD globally resulted in 1,662,339 deaths and 41,369,773 DALYs. Despite the high age-standardized death rate (20.73 per 100,000) and DALY rate (499.41 per 100,000), a declining trend was noted. This trend is reflected by the EAPCs of -0.35 for DALYs and - 0.67 for deaths. Notably, males and middle SDI countries exhibited higher rates of IHD, whereas high SDI regions such as High-income Asia Pacific and Western Europe showed decreasing trends in IHD. CONCLUSION: Over the past three decades, there has been a significant increase in IHD caused by HBMI, especially in low-middle and low SDI regions. This highlights the importance of targeted interventions in addressing this issue. Notably, regions including Central Asia, Eastern Europe, North Africa, and the Middle East have been heavily affected.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2024) conducted an observational in Ischemic heart disease. High body mass index vs. Unexposed/reference group was evaluated on Estimated annual percentage change (EAPC) in age-standardized death rate (EAPC -0.67, 95% CI -0.75 to -0.60). High body mass index-attributable ischemic heart disease resulted in 1,662,339 deaths globally in 2019, with the age-standardized death rate showing a declining trend (EAPC -0.67) from 1990 to 2019.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: